INFLAMMATORY BOWEL DISEASES is a premier journal published by Oxford University Press, Inc., dedicated to advancing research within the fields of gastroenterology and immunology. With an impressive impact factor reflecting its status as a Q1 category journal in both gastroenterology and immunology and allergy, it ranks 17th out of 167 in gastroenterology and 53rd out of 233 in immunology, underscoring its influence and authority within the scientific community. Since its inception in 1995 and continuing through to 2024, the journal has become an essential resource for researchers, healthcare professionals, and students, serving as a platform for the latest findings in the diagnosis, treatment, and management of inflammatory bowel diseases. While the journal operates under a subscription-based model, it is recognized for its rigorous peer-review process and commitment to publishing high-caliber, impactful studies that contribute significantly to understanding and treating these complex conditions.

Colorectal Disease, published by Wiley, is a premier journal dedicated to advancing research and clinical practice in the field of gastroenterology. With an impressive impact factor and ranked in the Q1 category for Gastroenterology according to 2023 metrics, this journal serves as a vital platform for researchers, clinicians, and students alike. Covering a diverse range of topics from clinical trials to innovative treatment practices, Colorectal Disease strives to disseminate high-quality research that informs effective treatment strategies for colorectal conditions. Since its inception in 1999, the journal has established itself as an essential resource, with its contributions placing it in the 76th percentile among its peers in Scopus rankings. While the journal is not open access, it provides a wealth of knowledge and insights that are crucial for anyone involved in gastrointestinal research and practice. The journal’s address is 111 River Street, Hoboken, NJ 07030-5774, United Kingdom, where it continues to champion excellence in colorectal health research until the end of 2024.

The Journal of Visceral Surgery, an esteemed publication from Elsevier Masson, offers a crucial platform for disseminating innovative research in the field of visceral surgery. Operating since 2010 and continually evolving through to 2024, this journal is dedicated to presenting high-quality studies and clinical findings that advance the practice and understanding of surgical techniques and patient care in visceral surgery. With an ISSN of 1878-7886 and a notable impact within the academic community, it achieved a Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in Surgery as of 2023, reflecting its growing influence in the surgical domain. Although it currently does not operate under an Open Access model, the journal remains committed to informing a diverse audience of scholars, practitioners, and students about pioneering methods, case studies, and reviews within the discipline. Positioned in France, the journal serves as an indispensable resource for enhancing surgical practice and fostering collaboration among professionals globally, making it a vital read for anyone invested in the advancement of visceral surgery.

COLOPROCTOLOGY is a specialized journal published by Springer, dedicated to advancing knowledge and understanding in the fields of Gastroenterology and Surgery. With an ISSN of 0174-2442 and an E-ISSN of 1615-6730, this journal holds a prominent position in the medical literature, despite being categorized in the Q4 quartile as per the latest metrics for both disciplines. The convergence of research published from 1998 to 2024 reflects the journal's long-standing commitment to addressing critical issues in coloproctology, offering insights into clinical practices, surgical techniques, and gastrointestinal disorders. While the journal does not currently provide open access options, it remains a vital resource for professionals, researchers, and students aiming to enhance their understanding of complex gastrointestinal health challenges. With its esteemed publisher, Springer, COLOPROCTOLOGY aims to foster innovation and scholarly dialogue within the medical community.

Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.

International Journal of Colorectal Disease is a prestigious peer-reviewed journal published by Springer that focuses on the evolving landscape of colorectal diseases. Established in 1986, this journal has served as a vital platform for researchers, healthcare professionals, and students to explore groundbreaking research, innovative treatment methodologies, and the latest advancements in gastroenterology. With an impressive impact factor and ranked in the Q2 category of gastroenterology by Scopus, it holds a prominent position in the academic community, currently occupying the 59th rank among 167 journals in the field, corresponding to the 64th percentile. Although it does not offer open access, the journal remains invaluable for those seeking in-depth analysis and comprehensive insights into colorectal health issues. As it continues through its convergence years until 2024, the International Journal of Colorectal Disease invites contributions that aim to bridge the gap between research and clinical practice, fostering a deeper understanding of colorectal disorders and enhancing patient care.

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

DIGESTIVE SURGERY, published by KARGER in Switzerland, is a leading journal at the forefront of its field, focusing on innovative surgical techniques and advancements in gastrointestinal surgery. With an ISSN of 0253-4886 and an E-ISSN of 1421-9883, this esteemed journal has been disseminating critical research since its inception in 1984, and is set to continue shaping the discipline until 2024. DIGESTIVE SURGERY holds an impressive impact factor, reflected in its 2023 ranking, positioned in the Q2 quartile for Gastroenterology and Q1 for Surgery. It is recognized within the Scopus database as #93 out of 551 in Surgery and #61 out of 167 in Gastroenterology, placing it in the top percentiles of both fields. While the journal is not open access, it remains a pivotal resource for practitioners, researchers, and students seeking to deepen their understanding of surgical practices and innovations that enhance patient care.

Crohns & Colitis 360, published by Oxford University Press, is a leading open access journal that has been at the forefront of gastrointestinal research since its launch in 2019. With an E-ISSN of 2631-827X, this journal aims to foster innovation and collaboration within the field of gastroenterology, focusing on diseases such as Crohn's disease and ulcerative colitis. As of 2023, it has earned a commendable Q2 ranking in the gastroenterology category, positioning it among the top 50% of journals in its field, with a Scopus rank of 99 out of 167. Crohns & Colitis 360 not only provides a platform for peer-reviewed research but also seeks to disseminate clinical guidelines, reviews, and groundbreaking studies, making it an essential resource for researchers, healthcare professionals, and students dedicated to advancing the understanding and treatment of inflammatory bowel diseases. Emphasizing accessibility, the journal has been open access since its inception, ensuring that cutting-edge research is readily available to a global audience. This commitment to knowledge sharing significantly enhances its impact and relevance in the ever-evolving landscape of gastroenterology.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.